Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase - Sirotnak,F.M.; Zakowski,M.F.; Miller,V.A. (Clin Cancer Res, 2000)